Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Gupta B, Bray F, Kumar N, Johnson NW. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: A case–control study from India.Cancer Epidemiol. 2017;51:7–14. [DOI] [PubMed]
Montero PH, Patel SG. Cancer of the oral cavity.Surg Oncol Clin N Am. 2015;24:491–508. [DOI] [PubMed] [PMC]
Bishop JA, Sciubba JJ, Westra WH. Squamous Cell Carcinoma of the Oral Cavity and Oropharynx.Surg Pathol Clin. 2011;4:1127–51. [DOI] [PubMed]
Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review.J Cancer Res Ther. 2016;12:458–63. [DOI] [PubMed]
Axéll T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people.Community Dent Oral Epidemiol. 1987;15:46–51. [DOI] [PubMed]
Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al.; American Dental Association Council on Scientific Affairs Expert Panel on Screening for Oral Squamous Cell Carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.J Am Dent Assoc. 2010;141:509–20. [DOI] [PubMed]
Bewley AF, Farwell DG. Oral leukoplakia and oral cavity squamous cell carcinoma.Clin Dermatol. 2017;35:461–7. [DOI] [PubMed]
Lapthanasupkul P, Poomsawat S, Punyasingh J. A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population.Quintessence Int. 2007;38:e448–55. [PubMed]
Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians.Aust Dent J. 2011;56:253–6. [DOI] [PubMed]
Olson MA, Rogers RS 3rd, Bruce AJ. Oral lichen planus.Clin Dermatol. 2016;34:495–504. [DOI] [PubMed]
Maymone MBC, Greer RO, Kesecker J, Sahitya PC, Burdine LK, Cheng AD, et al. Premalignant and malignant oral mucosal lesions: Clinical and pathological findings.J Am Acad Dermatol. 2019;81:59–71. [DOI] [PubMed]
Sharma M, Shetty SS, Radhakrishnan R. Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation.Recent Pat Anticancer Drug Discov. 2018;13:272–91. [DOI] [PubMed]
Lin WY, Chiu TY, Lee LT, Lin CC, Huang CY, Huang KC. Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men.Am J Clin Nutr. 2008;87:1204–11. [DOI] [PubMed]
Tseng CH. Betel nut chewing and incidence of newly diagnosed type 2 diabetes mellitus in Taiwan.BMC Res Notes. 2010;3:228. [DOI] [PubMed] [PMC]
Tseng CH. Betel nut chewing is associated with hypertension in Taiwanese type 2 diabetic patients.Hypertens Res. 2008;31:417–23. [DOI] [PubMed]
Tseng CH. Betel nut chewing and subclinical ischemic heart disease in diabetic patients.Cardiol Res Pract. 2010;2011:451489. [DOI] [PubMed] [PMC]
Tseng CH. Betel nut chewing is independently associated with urinary albumin excretion rate in type 2 diabetic patients.Diabetes Care. 2006;29:462–3. [DOI] [PubMed]
Petersen PE. Oral cancer prevention and control – the approach of the World Health Organization.Oral Oncol. 2009;45:454–60. [DOI] [PubMed]
Malki AM, Raad SB, Abu-El-Ruz R. Prevention of Oral Cancer.Dev Oral Cancer. 2017:193–217. [DOI]
Oji C, Chukwuneke F. Poor oral Hygiene may be the Sole Cause of Oral Cancer.J Maxillofac Oral Surg. 2012;11:379–83. [DOI] [PubMed] [PMC]
Khan Z. An overview of oral cancer in Indian subcontinent and recommendations to decrease its incidence.Webmed Cent Cancer. 2012;3:1–29. [DOI]
Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival.Oral Oncol. 2010;46:407–10. [DOI] [PubMed]
Tahir A, Nagi AH, Ullah E, Janjua OS. The role of mast cells and angiogenesis in well-differentiated oral squamous cell carcinoma.J Cancer Res Ther. 2013;9:387–91. [DOI] [PubMed]
Levitz JS, Bradley TP, Golden AL. Overview of smoking and all cancers.Med Clin North Am. 2004;88:1655–75. [DOI] [PubMed]
Neville BW, Day TA. Oral cancer and precancerous lesions.CA Cancer J Clin. 2002;52:195–215. [DOI] [PubMed]
D’souza S, Addepalli V. Preventive measures in oral cancer: An overview.Biomed Pharmacother. 2018;107:72–80. [DOI] [PubMed]
Irani S. New Insights into Oral Cancer—Risk Factors and Prevention: A Review of Literature.Int J Prev Med. 2020;11:202. [DOI] [PubMed] [PMC]
Inchingolo F, Santacroce L, Ballini A, Topi S, Dipalma G, Haxhirexha K, et al. Oral Cancer: A Historical Review.Int J Environ Res Public Health. 2020;17:3168. [DOI] [PubMed] [PMC]
Rivera C. Essentials of oral cancer.Int J Clin Exp Pathol. 2015;8:11884–94. [PubMed] [PMC]
Bunget AM, Dascălu IT, Coleș E, Țîrcă T, Stan M, Găman S, et al. Histopathological aspects in oral squamous cell carcinoma.J Dental Sci. 2018;3:000173. [DOI]
Hasan S, Elongovan S. Conventional and advanced diagnostic aids in oral cancer screening–the journey so far.Int J Pharm Pharm Sci. 2015;7:29–33.
Sudheendra U, Hs S, Raju S. Vital tissue staining in the diagnosis of oral precancer and cancer: Stains, technique, utility, and reliability.Clin Cancer Invest J. 2014;3:141–5. [DOI]
Yang Y, Rhodus NL, Ondrey FG, Wuertz BR, Chen X, Zhu Y, et al. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.PLoS One. 2014;9:e95389. [DOI] [PubMed] [PMC]
Weigum SE, Floriano PN, Redding SW, Yeh CK, Westbrook SD, McGuff HS, et al. Nano-bio-chip sensor platform for examination of oral exfoliative cytology.Cancer Prev Res (Phila). 2010;3:518–28. [DOI] [PubMed] [PMC]
Santos AP, Sugaya NN, Pinto Junior Ddos S, Lemos Junior CA. Fine needle aspiration biopsy in the oral cavity and head and neck region.Braz Oral Res. 2011;25:186–91. [DOI] [PubMed]
Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T. Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma.J Oral Pathol Med. 2000;29:303–7. [DOI] [PubMed]
Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun JL, Lopez-Lopez R, Muinelo-Romay L, Suarez-Cunqueiro MM. Liquid Biopsy in Oral Cancer.Int J Mol Sci. 2018;19:1704. [DOI] [PubMed] [PMC]
Figueiredo PT, Leite AF, Freitas AC, Nascimento LA, Cavalcanti MG, Melo NS, et al. Comparison between computed tomography and clinical evaluation in tumour/node stage and follow-up of oral cavity and oropharyngeal cancer.Dentomaxillofac Radiol. 2010;39:140–8. [DOI] [PubMed] [PMC]
Singh A, Thukral CL, Gupta K, Sood AS, Singla H, Singh K. Role of MRI in Evaluation of Malignant Lesions of Tongue and Oral Cavity.Pol J Radiol. 2017;82:92–9. [DOI] [PubMed] [PMC]
Bednarczyk K, Gawin M, Chekan M, Kurczyk A, Mrukwa G, Pietrowska M, et al. Discrimination of normal oral mucosa from oral cancer by mass spectrometry imaging of proteins and lipids.J Mol Histol. 2019;50:1–10. [DOI] [PubMed] [PMC]
Patil A, Prabhu V, Choudhari KS, Unnikrishnan VK, George SD, Ongole R, et al. Evaluation of high-performance liquid chromatography laser-induced fluorescence for serum protein profiling for early diagnosis of oral cancer.J Biomed Opt. 2010;15:067007. [DOI] [PubMed]
Ulaganathan G, Mohamed Niazi KT, Srinivasan S, Balaji VR, Manikandan D, Hameed KAS, et al. A Clinicopathological Study of Various Oral Cancer Diagnostic Techniques.J Pharm Bioallied Sci. 2017;9:S4–10. [PubMed] [PMC]
Ribeiro MFA, Oliveira MCM, Leite AC, Bruzinga FFB, Mendes PA, Grossmann SMC, et al. Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review.Oral Oncol. 2022;130:105936. [DOI] [PubMed]
Warnakulasuriya S, Kerr AR. Oral Cancer Screening: Past, Present, and Future.J Dent Res. 2021;100:1313–20. [DOI] [PubMed] [PMC]
Ramya K, Prasad KV, Niveditha H. Public oral primary preventive measures: An Indian perspective.J Int Oral Health. 2011;3:7–18.
Shah S, Kaur M. Biomarkers and chemopreventives in oral carcinogenesis and its prevention.J Oral Maxillofac Pathol. 2014;18:69–76. [DOI] [PubMed] [PMC]
Girod SC, Pfahl M. Retinoid actions and implications for prevention and therapy of oral cancer.Int J Oral Maxillofac Surg. 1996;25:69–73. [DOI] [PubMed]
Mehta A, Kaur G. Potential role of melatonin in prevention and treatment of oral carcinoma.Indian J Dent. 2014;5:86–91. [DOI] [PubMed] [PMC]
Narotzki B, Reznick AZ, Aizenbud D, Levy Y. Green tea: a promising natural product in oral health.Arch Oral Biol. 2012;57:429–35. [DOI] [PubMed]
Lewandowska U, Szewczyk K, Hrabec E, Janecka A, Gorlach S. Overview of metabolism and bioavailability enhancement of polyphenols.J Agric Food Chem. 2013;61:12183–99. [DOI] [PubMed]
Yasamineh S, Gholizadeh O, Ghafouri Kalajahi H, Yasamineh P, Firouzi Amandi A, Dadashpour M. Future Prospects of Natural Polymer-Based Drug Delivery Systems in Combating Lung Diseases. In: Dureja H, Adams J, Löbenberg R, Andreoli Pinto TdJ, Dua K, editors. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases. Singapore: Springer Nature Singapore; 2023. pp. 465–82.
Mignogna MD, Fedele S, Lo Russo L. The World Cancer Report and the burden of oral cancer.Eur J Cancer Prev. 2004;13:139–42. [DOI] [PubMed]
De Virgilio A, Costantino A, Mercante G, Petruzzi G, Sebastiani D, Franzese C, et al. Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma.Curr Oncol Rep. 2020;22:91. [DOI] [PubMed]
Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhesaj A, Darling M, et al. Oral cancer: A multicenter study.Med Oral Patol Oral Cir Bucal. 2018;23:e23–9. [DOI] [PubMed] [PMC]
Horn D, Zittel S, Moratin J, Metzger K, Ristow O, Krisam J, et al. Prospective feasibility analysis of salvage surgery in recurrent oral cancer in terms of quality of life.Oral Oncol. 2020;102:104580. [DOI] [PubMed]
Huang SH, O’Sullivan B. Oral cancer: Current role of radiotherapy and chemotherapy.Med Oral Patol Oral Cir Bucal. 2013;18:e233–40. [DOI] [PubMed] [PMC]
Ohmae M, Kato I, Fujita Y, Meshii N, Motoki A, Nakazawa M, et al. A novel method of intra-arterial chemotherapy for oral cancer.J Clin Orthod. 2018;36:e18086. [DOI]
Wang D, Duan X, Zhang Y, Meng Z, Wang J. Traditional Chinese medicine for oral squamous cell carcinoma: A Bayesian network meta-analysis protocol.Medicine (Baltimore). 2020;99:e22955. [DOI] [PubMed] [PMC]
Pilborough AE, Lambert DW, Khurram SA. Extranodal extension in oral cancer: A role for the nodal microenvironment?J Oral Pathol Med. 2019;48:863–70. [DOI] [PubMed]
Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al.; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish.Lancet Oncol. 2009;10:1033–4. [DOI] [PubMed]
Krishna A, Singh S, Kumar V, Pal US. Molecular concept in human oral cancer.Natl J Maxillofac Surg. 2015;6:9–15. [DOI] [PubMed] [PMC]
Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients.Cancer. 1984;53:563–8. [DOI] [PubMed]
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa.J Oral Pathol Med. 2007;36:575–80. [DOI] [PubMed]
Koontongkaew S. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.J Cancer. 2013;4:66–83. [DOI] [PubMed] [PMC]
Perez-Ordoñez B, Beauchemin M, Jordan RCK. Molecular biology of squamous cell carcinoma of the head and neck.J Clin Pathol. 2006;59:445–53. [DOI] [PubMed] [PMC]
Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection.Head Neck Oncol. 2011;3:33. [DOI] [PubMed] [PMC]
Sarode GS, Sarode SC, Maniyar N, Sharma N, Yerwadekar S, Patil S. Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders.Oncol Rev. 2019;13:424. [DOI] [PubMed] [PMC]
Lovreglio P, Bukvic N, Fustinoni S, Ballini A, Drago I, Foà V, et al. Lack of genotoxic effect in workers exposed to very low doses of 1,3-butadiene.Arch Toxicol. 2006;80:378–81. [DOI] [PubMed]
Boccellino M, Di Stasio D, Dipalma G, Cantore S, Ambrosio P, Coppola M, et al. Steroids and growth factors in oral squamous cell carcinoma: useful source of dental-derived stem cells to develop a steroidogenic model in new clinical strategies.Eur Rev Med Pharmacol Sci. 2019;23:8730–40. [DOI] [PubMed]
D’Silva NJ, Gutkind JS. Oral Cancer: Integration of Studies for Diagnostic and Therapeutic Precision.Adv Dent Res. 2019;30:45–9. [DOI] [PubMed] [PMC]
Tatullo M, Codispoti B, Pacifici A, Palmieri F, Marrelli M, Pacifici L, et al. Potential Use of Human Periapical Cyst-Mesenchymal Stem Cells (hPCy-MSCs) as a Novel Stem Cell Source for Regenerative Medicine Applications.Front Cell Dev Biol. 2017;5:103. [DOI] [PubMed] [PMC]
Petrosyan V, Kane G, Ameerally P. Oral Cancer Treatment Through the Ages: Part 2.J Oral Maxillofac Surg. 2019;77:1484–9. [DOI] [PubMed]
Hu S, Wang H, Yan D, Lu W, Gao P, Lou W, et al. Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.Cell Cycle. 2018;17:2284–95. [DOI] [PubMed] [PMC]
Adlravan E, Sepideh jR, Nejati K, Karimi MA, Mousazadeh H, Abbasi A, et al. Potential activity of free and PLGA/PEG nanoencapsulated nasturtium officinale extract in inducing cytotoxicity and apoptosis in human lung carcinoma A549 cells.J Drug Deliv Sci Technol. 2021;61:102256. [DOI]
Samadzadeh S, Mousazadeh H, Ghareghomi S, Dadashpour M, Babazadeh M, Zarghami N. In vitro anticancer efficacy of Metformin-loaded PLGA nanofibers towards the post-surgical therapy of lung cancer.J Drug Deliv Sci Technol. 2021;61:102318. [DOI]
Salmani Javan E, Lotfi F, Jafari-Gharabaghlou D, Mousazadeh H, Dadashpour M, Zarghami N. Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation.Asian Pac J Cancer Prev. 2022;23:519–27. [DOI] [PubMed] [PMC]
Alagheband Y, Jafari-gharabaghlou D, Imani M, Mousazadeh H, Dadashpour M, Firouzi-Amandi A, et al. Design and fabrication of a dual-drug loaded nano-platform for synergistic anticancer and cytotoxicity effects on the expression of leptin in lung cancer treatment.J Drug Deliv Sci Technol. 2022;73:103389. [DOI]
Mogheri F, Jokar E, Afshin R, Akbari AA, Dadashpour M, Firouzi-amandi A, et al. Co-delivery of metformin and silibinin in dual-drug loaded nanoparticles synergistically improves chemotherapy in human non-small cell lung cancer A549 cells.J Drug Deliv Sci Technol. 202166:102752. [DOI]
Pourgholi A, Dadashpour M, Mousapour A, Firouzi Amandi A, Zarghami N. Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets.Asian Pac J Cancer Prev. 2021;22:2587–96. [DOI] [PubMed] [PMC]
Clarke R. Challenges threaten, opportunity awaits hyperbaric medicine and the head and neck cancer patient.Undersea Hyperb Med. 2019;46:385–97. [PubMed]
Li B, Ren M, Zhou X, Han Q, Cheng L. Targeting tumor-associated macrophages in head and neck squamous cell carcinoma.Oral Oncol. 2020;106:104723. [DOI] [PubMed]
Li JH, Hsin PY, Hsiao YC, Chen BJ, Zhuang ZY, Lee CW, et al. A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer.Cancers (Basel). 2024;16:3017. [DOI] [PubMed] [PMC]
Mekala MR, Bangi BB, N J, Lebaka RR, Nadendla LK, Ginjupally U. Association of Diabetes with Oral Cancer- an Enigmatic Correlation.Asian Pac J Cancer Prev. 2020;21:809–14. [DOI] [PubMed] [PMC]
Liu J, Zhao J, Qiao X. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.Endocrinology. 2023;164:bqad139. [DOI] [PubMed]
Ji M, Lv Y, Chen C, Xing D, Zhou C, Zhao J, et al. Metformin inhibits oral squamous cell carcinoma progression through regulating RNA alternative splicing.Life Sci. 2023;315:121274. [DOI] [PubMed]
Wei J, Huang J, Kuang Y, Li Y, Zhong D, Song J. Metformin inhibits proliferation of oral squamous cell carcinoma cells by suppressing proteolysis of nerve growth factor receptor.Arch Oral Biol. 2021;121:104971. [DOI] [PubMed]
Zhou X, Hao Q, Liao P, Luo S, Zhang M, Hu G, et al. Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator.Elife. 2016;5:e15099. [DOI] [PubMed] [PMC]
Yin W, Liu Y, Liu X, Ma X, Sun B, Yu Z. Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway.Oncol Lett. 2021;21:31. [DOI] [PubMed] [PMC]
Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.J Hematol Oncol. 2022;15:129. [DOI] [PubMed] [PMC]
Gutkind JS, Molinolo AA, Wu X, Wang Z, Nachmanson D, Harismendy O, et al. Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.JCI Insight. 2021;6:e147096. [DOI] [PubMed] [PMC]
Curry JM, Johnson J, Mollaee M, Tassone P, Amin D, Knops A, et al. Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate.Front Oncol. 2018;8:436. [DOI] [PubMed] [PMC]
Najafi F, Rajati F, Sarokhani D, Bavandpour M, Moradinazar M. The Relationship between Metformin Consumption and Cancer Risk: An Updated Umbrella Review of Systematic Reviews and Meta-Analyses.Int J Prev Med. 2023;14:90. [DOI] [PubMed] [PMC]
Li H, Chen Y, Hu L, Yang W, Gao Z, Liu M, et al. Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses.Eur J Med Res. 2023;28:392. [DOI] [PubMed] [PMC]
Amengual-Cladera E, Morla-Barcelo PM, Morán-Costoya A, Sastre-Serra J, Pons DG, Valle A, et al. Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies.Biology (Basel). 2024;13:302. [DOI] [PubMed] [PMC]
Almeida-Nunes DL, Silvestre R, Dinis-Oliveira RJ, Ricardo S. Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins.Int J Mol Sci. 2023;25:323. [DOI] [PubMed] [PMC]
Fukuzawa K, Noguchi Y, Yoshikawa T, Saito A, Doi C, Makino T, et al. High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract.Cancer Lett. 1999;144:145–51. [DOI] [PubMed]
Tseng C. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Oncotarget. 2017;8:18802–10. [DOI] [PubMed] [PMC]
Tseng CH. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Aging (Albany NY). 2016;8:1636–49. [DOI] [PubMed] [PMC]
Tseng CH. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.Metabolism. 2018;85:223–6. [DOI] [PubMed]
Tseng CH. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.Oncotarget. 2017;8:3042–8. [DOI] [PubMed] [PMC]
Tseng CH. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.Liver Int. 2018;38:2018–27. [DOI] [PubMed]
Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.Nature. 2014;510:542–6. [DOI] [PubMed] [PMC]
Tseng CH. Metformin use and cervical cancer risk in female patients with type 2 diabetes.Oncotarget. 2016;7:59548–55. [DOI] [PubMed] [PMC]
Tseng CH. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.Front Endocrinol (Lausanne). 2022;13:1036885. [DOI] [PubMed] [PMC]
McNutt M. Cancer immunotherapy.Science. 2013;342:1417. [DOI] [PubMed]
Mei Z, Huang J, Qiao B, Lam AK. Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma.Int J Oral Sci. 2020;12:16. [DOI] [PubMed] [PMC]
Mohan SP, Bhaskaran MK, George AL, Thirutheri A, Somasundaran M, Pavithran A. Immunotherapy in Oral Cancer.J Pharm Bioallied Sci. 2019;11:S107–11. [DOI] [PubMed] [PMC]
Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, et al. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.Clin Cancer Res. 2017;23:3072–83. [DOI] [PubMed] [PMC]
Shandilya J, Swaminathan V, Gadad SS, Choudhari R, Kodaganur GS, Kundu TK. Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation.Mol Cell Biol. 2009;29:5115–27. [DOI] [PubMed] [PMC]
Ohnishi Y, Sakamoto T, Zhengguang L, Yasui H, Hamada H, Kubo H, et al. Curcumin inhibits epithelial-mesenchymal transition in oral cancer cells via c-Met blockade.Oncol Lett. 2020;19:4177–82. [DOI] [PubMed] [PMC]
Liu C, Wang M, Zhang H, Li C, Zhang T, Liu H, et al. Tumor microenvironment and immunotherapy of oral cancer.Eur J Med Res. 2022;27:198. [DOI] [PubMed] [PMC]
Rohaan MW, Wilgenhof S, Haanen JBAG. Adoptive cellular therapies: the current landscape.Virchows Arch. 2019;474:449–61. [DOI] [PubMed] [PMC]
Dranoff G. Cytokines in cancer pathogenesis and cancer therapy.Nat Rev Cancer. 2004;4:11–22. [DOI] [PubMed]
Faghfuri E, Pourfarzi F, Faghfouri AH, Abdoli Shadbad M, Hajiasgharzadeh K, Baradaran B. Recent developments of RNA-based vaccines in cancer immunotherapy.Expert Opin Biol Ther. 2021;21:201–18. [DOI] [PubMed]
Gene therapy for human genetic disease?Science. 1972;178:648–9. [PubMed]
Chen J, Guo Z, Tian H, Chen X. Production and clinical development of nanoparticles for gene delivery.Mol Ther Methods Clin Dev. 2016;3:16023. [DOI] [PubMed] [PMC]
Chen J, Jiao ZX, Lin L, Guo ZP, Xu CN, Li YH, et al. Polylysine-modified polyethylenimines as siRNA carriers for effective tumor treatment.Chin J Polym Sci. 2015;33:830–7. [DOI]
Hu YY, Lin L, Guo Z, Chen J, Maruyama A, Tian H, et al. In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy.Chinese Chemical Letters. 2021;32:1770–4. [DOI]
Zuckerman JE, Davis ME. Clinical experiences with systemically administered siRNA-based therapeutics in cancer.Nat Rev Drug Discov. 2015;14:843–56. [DOI] [PubMed]
Man A, Santacroce L, Jacob R, Mare A, Man L. Antimicrobial Activity of Six Essential Oils Against a Group of Human Pathogens: A Comparative Study.Pathogens. 2019;8:15. [DOI] [PubMed] [PMC]
Ballini A, Cantore S, Dedola A, Santacroce L, Laino L, Cicciù M, et al. IL-1 haplotype analysis in periodontal disease.J Biol Regul Homeost Agents. 2018;32:433–7. [PubMed]
Giudice G, Cutrignelli DA, Sportelli P, Limongelli L, Tempesta A, Gioia GD, et al. Rhinocerebral Mucormycosis with Orosinusal Involvement: Diagnostic and Surgical Treatment Guidelines.Endocr Metab Immune Disord Drug Targets. 2016;16:264–9. [DOI] [PubMed]
Ballini A, Cantore S, Farronato D, Cirulli N, Inchingolo F, Papa F, et al. Periodontal disease and bone pathogenesis: the crosstalk between cytokines and porphyromonas gingivalis.J Biol Regul Homeost Agents. 2015;29:273–81. [PubMed]
